38 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Integrated Media Technology Limited IMTE shares jumped 60 percent to $12.70.
• DAVIDsTEA Inc. DTEA shares gained 56.7 percent to $3.995 after declining 5.56 percent on Monday.
• India Globalization Capital, Inc. IGC shares climbed 52 percent to $13.71 after surging 39.84 percent on Monday.
• Therapix Biosciences Ltd. TRPX shares climbed 42.3 percent to $6.50.
• Pyxus International, Inc. PYX gained 27.02 percent to close at $29.43 after its Canadian subsidiary, Goldleaf Pharm, received a cannabis cultivation license from Health Canada.
• Antares Pharma, Inc. ATRS surged 16 percent to $3.78.
• Inovio Pharmaceuticals, Inc. INO gained 15.7 percent to $6.19 following a paper published in a major cancer journal. Stifel Nicolaus reinstated Inovio Pharmaceuticals with a Buy rating.
• Synthetic Biologics, Inc. SYN climbed 14.7 percent to $2.97.
• Level Brands, Inc. LEVB rose 12.7 percent to $6.75 after climbing 65.01 percent on Monday.
• Atomera Incorporated ATOM climbed 12.4 percent to $6.18 after licensing MST Technology to STMicroelectronics.
• Novan, Inc. NOVN gained 11.3 percent to $3.14.
• Clovis Oncology, Inc. CLVS rose 11 percent to $32.35 after receiving Breakthrough Therapy designation from the FDA for its Rubraca (rucaparib) for the treatment of BRCA1/2-mutated metastatic castration resistant prostate cancer.
• Companhia Paranaense de Energia ADR ELP climbed 10.3 percent to $5.78.
• Centrais Elétricas Brasileiras S.A. - Eletrobras EBR shares rose 9.8 percent to $4.14.
• Gol Linhas Aereas Inteligentes SA GOL gained 9.6 percent to $5.80.
• Infinity Pharmaceuticals, Inc. INFI climbed 8.8 percent to $2.84.
• Omeros Corporation OMER rose 6.6 percent to $14.88. Omeros dipped 42.81 percent Monday after the company released additional data Monday from the company’s OMS721 clinical trial in renal disease.
• Origin Agritech Limited SEED gained 6.3 percent to $5.376 after the company announced Origin e-Commune Network and a new joint venture with five major agricultural product distributors in the Hubei Province.
• PermRock Royalty Trust PRT gained 6.3 percent to $12.65. Stifel Nicolaus upgraded PermRock Royalty Trust from Hold to Buy.
• Verastem, Inc. VSTM rose 5.5 percent to $6.875 after dropping 10.14 percent on Monday.

Check out these big penny stock gainers and losers

Losers

• Stitch Fix, Inc. SFIX shares fell 32.5 percent to $30.1241. Stitch Fix reported upbeat earnings for its fourth quarter, while sales missed estimates.
• Greenpro Capital Corp. GRNQ shares dipped 30.3 percent to $6.90 after jumping 157.81 percent on Monday.
• Jaguar Health Inc JAGX shares dropped 24 percent to $0.6384. Jaguar Health priced its 15 million common share offering at $0.60 per share.
• Acasti Pharma Inc ACST shares fell 19.8 percent to $1.26 after reported an offering of common shares to holders of its outstanding convertible debentures.
• Ring Energy, Inc. REI fell 17.3 percent to $8.805.
• Mesoblast Limited MESO dropped 15.4 percent to $7.28.
• Aduro BioTech, Inc. ADRO fell 14.4 percent to $6.15.
• Neonode Inc. NEON dropped 11.3 percent to $3.3001.
• Net Element, Inc. NETE dropped 10.6 percent to $4.750 after the company announced plans to joint venture with Bank Sputnik in launching new payment processing center.
• Voyager Therapeutics, Inc. VYGR dipped 9.9 percent to $16.26.
• Avenue Therapeutics, Inc. ATXI fell 9.4 percent to $2.50.
• Bright Scholar Education Holdings Limited BEDU dropped 8.8 percent to $11.31 after the company agreed to acquire Bournemouth Collegiate School. Morgan Stanley downgraded Bright Scholar Education from Overweight to Equal-Weight.
• New Age Beverages Corporation NBEV fell 8.2 percent to $8.2201 after climbing 67.29 percent on Monday.
• Tilray, Inc. TLRY slipped 7.3 percent to $152.91 after climbing 14.87 percent on Monday.
• Veoneer, Inc. VNE shares fell 6.5 percent to $51.90. UBS downgraded Veoneer from Neutral to Sell.
• HUYA Inc. HUYA shares fell 5.7 percent to $21.22 after dropping 4.58 percent on Monday.
• Neptune Wellness Solutions Inc. NEPT fell 5.4 percent to $4.35 after climbing 18.56 percent on Monday.
• Intercept Pharmaceuticals, Inc. ICPT dropped 4.8 percent to $120.42. Raymond James downgraded Intercept Pharmaceuticals from Strong Buy to Outperform.